Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sami Shousha

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Nature Communications|May 11, 2019
SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancerYlenia Perone, Aaron J Farrugia, Alba Rodríguez-Meira, et al.
The Journal of Pathology|October 22, 2011
Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancersDaniel Wetterskog, Maria Angeles Lopez-Garcia, Maryou B Lambros, et al.
Nature Medicine|July 25, 2018
Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancerDarren K Patten, Giacomo Corleone, Balázs Győrffy, et al.
Histopathology|February 13, 2013
Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutationsDaniel Wetterskog, Paul M Wilkerson, Daniel N Rodrigues, et al.
Scientific Reports|March 29, 2017
Characterisation of male breast cancer: a descriptive biomarker study from a large patient seriesMatthew P Humphries, Sreekumar Sundara Rajan, Hedieh Honarpisheh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2016
Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor-Positive Breast CancerHetal Patel, Rezvan Abduljabbar, Chun-Fui Lai, et al.
Breast Cancer Research and Treatment|November 19, 2011
A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differencesAbeer M Shaaban, Graham R Ball, Rebecca A Brannan, et al.
Oncotarget|July 29, 2015
The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancerLuca Magnani, Darren K Patten, Van T M Nguyen, et al.
British Journal of Cancer|September 18, 2024
Testing of rapid evaporative mass spectrometry for histological tissue classification and molecular diagnostics in a multi-site studyMartin Kaufmann, Pierre-Maxence Vaysse, Adele Savage, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2016
A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast CancerMatthew P Humphries, Sreekumar Sundara Rajan, Alastair Droop, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Nature Communications|May 11, 2019
SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancerYlenia Perone, Aaron J Farrugia, Alba Rodríguez-Meira, et al.
The Journal of Pathology|October 22, 2011
Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancersDaniel Wetterskog, Maria Angeles Lopez-Garcia, Maryou B Lambros, et al.
Nature Medicine|July 25, 2018
Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancerDarren K Patten, Giacomo Corleone, Balázs Győrffy, et al.
Histopathology|February 13, 2013
Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutationsDaniel Wetterskog, Paul M Wilkerson, Daniel N Rodrigues, et al.
Scientific Reports|March 29, 2017
Characterisation of male breast cancer: a descriptive biomarker study from a large patient seriesMatthew P Humphries, Sreekumar Sundara Rajan, Hedieh Honarpisheh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2016
Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor-Positive Breast CancerHetal Patel, Rezvan Abduljabbar, Chun-Fui Lai, et al.
Breast Cancer Research and Treatment|November 19, 2011
A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differencesAbeer M Shaaban, Graham R Ball, Rebecca A Brannan, et al.
Oncotarget|July 29, 2015
The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancerLuca Magnani, Darren K Patten, Van T M Nguyen, et al.
British Journal of Cancer|September 18, 2024
Testing of rapid evaporative mass spectrometry for histological tissue classification and molecular diagnostics in a multi-site studyMartin Kaufmann, Pierre-Maxence Vaysse, Adele Savage, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2016
A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast CancerMatthew P Humphries, Sreekumar Sundara Rajan, Alastair Droop, et al.
Pageof 6